Breakthrough T1d (FKA Juvenile Diabetes Research Foundation International)

Based in DC

🤖

AI Overview

With $2.5M in lobbying spend across 35 quarterly filings, Breakthrough T1d (FKA Juvenile Diabetes Research Foundation International) is a significant lobbying presence. They deploy 12 individual lobbyists Their lobbying covers 3 issue areas. Active from 2018 to 2025.

$2.5M
Total Spend
8
Years Active
1
Firms Hired
12
Lobbyists Deployed
3
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$320K
2019$320K
2020$230K
2021$200K
2022$350K
2023$400K
2024$400K
2025$320K

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Budget/Appropriations, Health Issues

  • S. 870 - Chronic Care
  • S. 1827 - Kids Act of 2017
  • H.R. 3921 - Healthy Kids Act
  • no specific bill - medicare coverage and reimbursement, continuous glucose monitors, chronic care, artificial pancreas
  • H.R. 1625 - Consolidated Appropriations Act of 2018
  • H.R. 1892 - Bipartisan Budget Act of 2018
  • Implementation of the Special Diabetes Program, renewal of the Special Diabetes Program
  • PL 114-255 - 21st Century Cures, implementation
  • H.R. 2430 - FDA Reauthorization Act of 2017
  • ***, no specific b
  • H.R. 1625 - Consolidated Appropriations Act of 2018
  • H.R. 1892 - Bipartisan Budget Act of 2018
  • 2019 Appropriations
  • Implementation of the Special Diabetes Program, renewal of the Special Diabetes Program, National Chronic Care Commission
  • PL 114-255 - 21st Century Cures, implementation
  • H.R. 2430 - FDA Reauthorizatio

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.